Cargando…
PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial–Mesenchymal Transition in Uveal Melanoma
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UM develops and is sustained by inflammation and immunosuppression from the tumor microenvironment (TME). This study sought to identify a reliable TME-related biomarker that could provide survival prediction and new ins...
Autores principales: | Meng, Zhishang, Chen, Yanzhu, Wu, Wenyi, Yan, Bin, Zhang, Lusi, Chen, Huihui, Meng, Yongan, Liang, Youling, Yao, Xiaoxi, Luo, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914230/ https://www.ncbi.nlm.nih.gov/pubmed/35281030 http://dx.doi.org/10.3389/fimmu.2022.754645 |
Ejemplares similares
-
Exploring the Immune Infiltration Landscape and M2 Macrophage-Related Biomarkers of Proliferative Diabetic Retinopathy
por: Meng, Zhishang, et al.
Publicado: (2022) -
The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition
por: Du, Wenjiao, et al.
Publicado: (2021) -
PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition
por: Yao, Jibin, et al.
Publicado: (2021) -
miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016) -
Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)